BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 34670862)

  • 1. Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development.
    Shimomura K; Hattori N; Iida N; Muranaka Y; Sato K; Shiraishi Y; Arai Y; Hama N; Shibata T; Narushima D; Kato M; Takamaru H; Okamoto K; Takeda H
    Nat Commun; 2023 Oct; 14(1):6514. PubMed ID: 37845228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
    Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
    World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
    Sotgia F; Martinez-Outschoorn UE; Pavlides S; Howell A; Pestell RG; Lisanti MP
    Breast Cancer Res; 2011 Jul; 13(4):213. PubMed ID: 21867571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP.
    Nakagama H; Ochiai M; Ubagai T; Tajima R; Fujiwara K; Sugimura T; Nagao M
    Mutat Res; 2002 Sep; 506-507():137-44. PubMed ID: 12351153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epithelial-Stromal Microenvironment in Early Colonic Neoplasia.
    Ideta T; Li B; Flynn C; Igarashi Y; Lowman G; Looney T; Devers TJ; Birk J; Forouhar F; Giardina C; Rosenberg DW
    Mol Cancer Res; 2022 Jan; 20(1):56-61. PubMed ID: 34670862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development.
    Mo A; Jackson S; Varma K; Carpino A; Giardina C; Devers TJ; Rosenberg DW
    Mol Cancer Res; 2016 Sep; 14(9):795-804. PubMed ID: 27353028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal Cell PD-L1 Inhibits CD8
    O'Malley G; Treacy O; Lynch K; Naicker SD; Leonard NA; Lohan P; Dunne PD; Ritter T; Egan LJ; Ryan AE
    Cancer Immunol Res; 2018 Nov; 6(11):1426-1441. PubMed ID: 30228206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
    Fitzgerald S; Espina V; Liotta L; Sheehan KM; O'Grady A; Cummins R; O'Kennedy R; Kay EW; Kijanka GS
    J Transl Med; 2018 Apr; 16(1):89. PubMed ID: 29631612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
    Vellinga TT; den Uil S; Rinkes IH; Marvin D; Ponsioen B; Alvarez-Varela A; Fatrai S; Scheele C; Zwijnenburg DA; Snippert H; Vermeulen L; Medema JP; Stockmann HB; Koster J; Fijneman RJ; de Rooij J; Kranenburg O
    Oncogene; 2016 Oct; 35(40):5263-5271. PubMed ID: 26996663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
    Bian Y; Knobloch TJ; Sadim M; Kaklamani V; Raji A; Yang GY; Weghorst CM; Pasche B
    Hum Mol Genet; 2007 Dec; 16(24):3128-35. PubMed ID: 17890272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer.
    Irrazabal T; Thakur BK; Kang M; Malaise Y; Streutker C; Wong EOY; Copeland J; Gryfe R; Guttman DS; Navarre WW; Martin A
    Nat Commun; 2020 Apr; 11(1):1802. PubMed ID: 32286276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL22 Signaling in the Tumor Environment.
    Röhrle N; Knott MML; Anz D
    Adv Exp Med Biol; 2020; 1231():79-96. PubMed ID: 32060848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.
    Guo Y; Ayers JL; Carter KT; Wang T; Maden SK; Edmond D; Newcomb P P; Li C; Ulrich C; Yu M; Grady WM
    Aging Cell; 2019 Dec; 18(6):e13013. PubMed ID: 31389184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond.
    Kazanietz MG; Durando M; Cooke M
    Front Endocrinol (Lausanne); 2019; 10():471. PubMed ID: 31354634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.